Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Blood Pressure, Low

pyrrolidine dithiocarbamate has been researched along with Blood Pressure, Low in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, SF; Malik, AB; Ye, X1
Boyle, EM; Canty, TG; Caps, MT; Farr, AL; Frank, N; Kovacich, JC; Morgan, EN; Pohlman, TH; Verrier, ED1

Other Studies

2 other study(ies) available for pyrrolidine dithiocarbamate and Blood Pressure, Low

ArticleYear
In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock.
    Journal of immunology (Baltimore, Md. : 1950), 1997, Oct-15, Volume: 159, Issue:8

    Topics: Animals; Calcium; Disease Models, Animal; Enzyme Activation; Enzyme Induction; Hypotension; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Shock, Septic; Thiocarbamates; Time Factors

1997
Inhibition of the transcriptional activator protein nuclear factor kappaB prevents hemodynamic instability associated with the whole-body inflammatory response syndrome.
    The Journal of thoracic and cardiovascular surgery, 1999, Volume: 118, Issue:1

    Topics: Acidosis; Animals; Antioxidants; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hypotension; Infusions, Intravenous; Interleukin-1; NF-kappa B; Proline; Pyrrolidines; Rabbits; Random Allocation; Systemic Inflammatory Response Syndrome; Thiocarbamates

1999